251 related articles for article (PubMed ID: 32648006)
1. Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency.
Slatter MA; Gennery AR
Curr Allergy Asthma Rep; 2020 Jul; 20(10):57. PubMed ID: 32648006
[TBL] [Abstract][Full Text] [Related]
2. Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.
Xing M; Oksenych V
FEBS Open Bio; 2019 Jul; 9(7):1315-1326. PubMed ID: 31141305
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in lymphocytes.
Hung PJ; Chen BR; George R; Liberman C; Morales AJ; Colon-Ortiz P; Tyler JK; Sleckman BP; Bredemeyer AL
Cell Cycle; 2017 Feb; 16(3):286-295. PubMed ID: 27830975
[TBL] [Abstract][Full Text] [Related]
4. Cernunnos/XLF: a new player in DNA double-strand break repair.
Yano K; Morotomi-Yano K; Akiyama H
Int J Biochem Cell Biol; 2009 Jun; 41(6):1237-40. PubMed ID: 18992362
[TBL] [Abstract][Full Text] [Related]
5. PAXX and XLF DNA repair factors are functionally redundant in joining DNA breaks in a G1-arrested progenitor B-cell line.
Kumar V; Alt FW; Frock RL
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10619-24. PubMed ID: 27601633
[TBL] [Abstract][Full Text] [Related]
6. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
Slack J; Albert MH; Balashov D; Belohradsky BH; Bertaina A; Bleesing J; Booth C; Buechner J; Buckley RH; Ouachée-Chardin M; Deripapa E; Drabko K; Eapen M; Feuchtinger T; Finocchi A; Gaspar HB; Ghosh S; Gillio A; Gonzalez-Granado LI; Grunebaum E; Güngör T; Heilmann C; Helminen M; Higuchi K; Imai K; Kalwak K; Kanazawa N; Karasu G; Kucuk ZY; Laberko A; Lange A; Mahlaoui N; Meisel R; Moshous D; Muramatsu H; Parikh S; Pasic S; Schmid I; Schuetz C; Schulz A; Schultz KR; Shaw PJ; Slatter MA; Sykora KW; Tamura S; Taskinen M; Wawer A; Wolska-Kuśnierz B; Cowan MJ; Fischer A; Gennery AR; ; ; ;
J Allergy Clin Immunol; 2018 Jan; 141(1):322-328.e10. PubMed ID: 28392333
[TBL] [Abstract][Full Text] [Related]
7. Primary immunodeficiency syndromes associated with defective DNA double-strand break repair.
Gennery AR
Br Med Bull; 2006; 77-78():71-85. PubMed ID: 16971555
[TBL] [Abstract][Full Text] [Related]
8. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks.
Yu Y; Mahaney BL; Yano K; Ye R; Fang S; Douglas P; Chen DJ; Lees-Miller SP
DNA Repair (Amst); 2008 Oct; 7(10):1680-92. PubMed ID: 18644470
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation for DNA Double Strand Breakage Repair Disorders.
Wolska-Kuśnierz B; Gennery AR
Front Pediatr; 2019; 7():557. PubMed ID: 32010653
[TBL] [Abstract][Full Text] [Related]
10. PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice.
Liu X; Shao Z; Jiang W; Lee BJ; Zha S
Nat Commun; 2017 Jan; 8():13816. PubMed ID: 28051062
[TBL] [Abstract][Full Text] [Related]
11. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining.
Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G
DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742
[TBL] [Abstract][Full Text] [Related]
12. The clinical impact of deficiency in DNA non-homologous end-joining.
Woodbine L; Gennery AR; Jeggo PA
DNA Repair (Amst); 2014 Apr; 16():84-96. PubMed ID: 24629483
[TBL] [Abstract][Full Text] [Related]
13. Leaky severe combined immunodeficiency in mice lacking non-homologous end joining factors XLF and MRI.
Castañeda-Zegarra S; Zhang Q; Alirezaylavasani A; Fernandez-Berrocal M; Yao R; Oksenych V
Aging (Albany NY); 2020 Dec; 12(23):23578-23597. PubMed ID: 33289702
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethality between DNA repair factors Xlf and Paxx is rescued by inactivation of Trp53.
Castañeda-Zegarra S; Xing M; Gago-Fuentes R; Sæterstad S; Oksenych V
DNA Repair (Amst); 2019 Jan; 73():164-169. PubMed ID: 30579708
[TBL] [Abstract][Full Text] [Related]
15. Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutations.
Schwartz M; Oren YS; Bester AC; Rahat A; Sfez R; Yitzchaik S; de Villartay JP; Kerem B
PLoS One; 2009; 4(2):e4516. PubMed ID: 19223975
[TBL] [Abstract][Full Text] [Related]
16. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells.
Fattah F; Lee EH; Weisensel N; Wang Y; Lichter N; Hendrickson EA
PLoS Genet; 2010 Feb; 6(2):e1000855. PubMed ID: 20195511
[TBL] [Abstract][Full Text] [Related]
17. Absence of XRCC4 and its paralogs in human cells reveal differences in outcomes for DNA repair and V(D)J recombination.
Ruis B; Molan A; Takasugi T; Hendrickson EA
DNA Repair (Amst); 2020 Jan; 85():102738. PubMed ID: 31731258
[TBL] [Abstract][Full Text] [Related]
18. Interplay between Cernunnos-XLF and nonhomologous end-joining proteins at DNA ends in the cell.
Wu PY; Frit P; Malivert L; Revy P; Biard D; Salles B; Calsou P
J Biol Chem; 2007 Nov; 282(44):31937-43. PubMed ID: 17720816
[TBL] [Abstract][Full Text] [Related]
19. Extensive ssDNA end formation at DNA double-strand breaks in non-homologous end-joining deficient cells during the S phase.
Karlsson KH; Stenerlöw B
BMC Mol Biol; 2007 Oct; 8():97. PubMed ID: 17963495
[TBL] [Abstract][Full Text] [Related]
20. DNA double strand break repair via non-homologous end-joining.
Davis AJ; Chen DJ
Transl Cancer Res; 2013 Jun; 2(3):130-143. PubMed ID: 24000320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
